Cellectar Biosciences, Inc. (CLRB) announced the closing of its previously announced underwritten public offering, Yesterday after markets close. The offering generated gross proceeds of approximately $6.9 million prior to deducting underwriting commissions and offering expenses. The offering includes 1,045,000 Class A Units, with each Class A Unit containing one share of common stock and one common warrant to purchase one share of common stock. Additionally, there are 335,000 Class B Units, each comprising one pre-funded common stock purchase warrant to acquire one share of common stock and one common warrant.
The price per Class A Unit is $5.00 and the price per Class B Unit is $4.99. The common warrants have an exercise price of $5.25 per share, are exercisable upon issuance, and have a term expiring five years from issuance.
